Skip to main content
. 2025 Aug 12;17(16):2633. doi: 10.3390/cancers17162633
Hb Hemoglobin
RP Radical Prostatectomy
RFS Recurrence Free Survival
TFS Adjuvant Treatment Free Survival
MFS Metastasis Free Survival
ISUP International Society for Urological Pathology
≥pT3 Extraprostatic Disease
OR Odds Ratio
HR Hazard Ratio
IQR Interquartile Range
95%-CI 95% Confidence Interval
PSM Positive Surgical Margin
PSA Prostate Specific Antigen
pN1 Positive Pathological Nodal Status
OS Overall Survival
CSS Cancer Specific Survival
DFS Disease Free Survival
SC Spearman Coefficient
UTUC Upper Tract Urothelial Carcinoma
EPO Erythropoietin